Follow
Vladimir Gilca
Vladimir Gilca
Institut national de santé publique
Verified email at inspq.qc.ca
Title
Cited by
Cited by
Year
Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada
C Sauvageau, B Duval, V Gilca, F Lavoie, M Ouakki
BMC Public Health 7, 1-6, 2007
1592007
Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results
A Krawczyk, B Knäuper, V Gilca, E Dubé, S Perez, K Joyal-Desmarais, ...
Human vaccines & immunotherapeutics 11 (2), 322-329, 2015
1062015
Vaccination against human papillomavirus: a baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs
B Duval, V Gilca, S McNeil, S Dobson, D Money, IM Gemmill, ...
Vaccine 25 (45), 7841-7847, 2007
1062007
Cervical cancer prevention by vaccination: nurses’ knowledge, attitudes and intentions
B Duval, V Gilca, N Boulianne, K Pielak, B Halperin, MA Simpson, ...
Journal of advanced nursing 65 (3), 499-508, 2009
1052009
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)
DM Skowronski, NZ Janjua, G De Serres, D Purych, V Gilca, ...
The Journal of infectious diseases 206 (12), 1852-1861, 2012
1032012
Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without …
S Carazo, DM Skowronski, M Brisson, S Barkati, C Sauvageau, ...
The Lancet Infectious Diseases 23 (1), 45-55, 2023
972023
Determinants of parents’ decision to vaccinate their children against rotavirus: results of a longitudinal study
E Dubé, JA Bettinger, B Halperin, R Bradet, F Lavoie, C Sauvageau, ...
Health education research 27 (6), 1069-1080, 2012
932012
Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada
P De Wals, G Deceuninck, B Lefebvre, R Tsang, D Law, G De Serres, ...
Clinical infectious diseases 64 (9), 1263-1267, 2017
852017
Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies
AM Anonychuk, AC Tricco, CT Bauch, B Pham, V Gilca, B Duval, ...
Pharmacoeconomics 26, 17-32, 2008
852008
Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country
B Duval, V Gîlca, N Boulianne, P De Wals, R Massé, G Trudeau, ...
The Pediatric infectious disease journal 24 (3), 213-218, 2005
822005
Cost-utility of universal hepatitis A vaccination in Canada
CT Bauch, AM Anonychuk, BZ Pham, V Gilca, B Duval, MD Krahn
Vaccine 25 (51), 8536-8548, 2007
742007
Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine
V Gilca, G De Serres, N Boulianne, D Murphy, P De Wals, M Ouakki, ...
Vaccine 31 (3), 448-451, 2013
622013
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review
B Pham, B Duval, G De Serres, V Gilca, AC Tricco, J Ochnio, ...
BMC Infectious diseases 5, 1-11, 2005
602005
Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis
AC Tricco, CH Ng, V Gilca, A Anonychuk, B Pham, S Berliner
BMC infectious diseases 11, 1-15, 2011
562011
Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A (H1N1) pandemic vaccine
E Dubé, V Gilca, C Sauvageau, N Boulianne, FD Boucher, JA Bettinger, ...
BMC Research Notes 3, 1-5, 2010
562010
Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal …
S Perez, O Tatar, GK Shapiro, E Dubé, G Ogilvie, J Guichon, V Gilca, ...
BMC Public Health 16, 1-17, 2016
532016
Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey
V Gilca, N Boulianne, E Dubé, C Sauvageau, M Ouakki
International Journal of Nursing Studies 46 (9), 1219-1235, 2009
522009
Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in Quebec, Canada
S Carazo, DM Skowronski, M Brisson, C Sauvageau, N Brousseau, ...
JAMA network open 5 (10), e2236670-e2236670, 2022
492022
Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
V Gilca, G De Serres, ME Hamelin, G Boivin, M Ouakki, N Boulianne, ...
Vaccine 30 (1), 35-41, 2011
492011
Burden of acute otitis media on Canadian families
E Dubé, P De Wals, V Gilca, N Boulianne, M Ouakki, F Lavoie, R Bradet
Canadian Family Physician 57 (1), 60-65, 2011
472011
The system can't perform the operation now. Try again later.
Articles 1–20